INSM insider disclosures
Explore public SEC filings by reporting investor and stock. Filings can appear after the activity they describe. Joint filing lines link to each reporting owner’s profile.
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source | Follow |
|---|---|---|---|---|---|---|---|
| Schaeffer Orlov S Nicole Chief People Strategy Officer · INSMED Inc | INSM INSMED Inc | Exercise or conversionFiling detailsSEC transaction code M Stock Option (right to buy) · Derivative security · Direct ownership · Reported balance after transaction: 0 · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. · The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. | 2026-11-19 | 2026-11-20 | 45,700 shares/units | SEC 4 | Follow |
| Schaeffer Orlov S Nicole Chief People Strategy Officer · INSMED Inc | INSM INSMED Inc | Exercise or conversionFiling detailsSEC transaction code M Stock Option (right to buy) · Derivative security · Direct ownership · Reported balance after transaction: 0 · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. · The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. | 2026-11-19 | 2026-11-20 | 55,400 shares/units | SEC 4 | Follow |
| Schaeffer Orlov S Nicole Chief People Strategy Officer · INSMED Inc | INSM INSMED Inc | SellFiling detailsSEC transaction code S Common Stock · Direct ownership · Reported balance after transaction: 41895 · SEC code covers open-market or private transactions · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. · This is the weighted average sales price representing 2,262 shares sold at prices ranging from $147.38 to $148.01 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. | 2026-11-19 | 2026-11-20 | ≈ $333,645.00 2,262 shares/units | SEC 4 | Follow |
| Schaeffer Orlov S Nicole Chief People Strategy Officer · INSMED Inc | INSM INSMED Inc | SellFiling detailsSEC transaction code S Common Stock · Direct ownership · Reported balance after transaction: 44157 · SEC code covers open-market or private transactions · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. · This is the weighted average sales price representing 8,539 shares sold at prices ranging from $146.10 to $147.09 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. | 2026-11-19 | 2026-11-20 | ≈ $1,253,183.64 8,539 shares/units | SEC 4 | Follow |
| Schaeffer Orlov S Nicole Chief People Strategy Officer · INSMED Inc | INSM INSMED Inc | SellFiling detailsSEC transaction code S Common Stock · Direct ownership · Reported balance after transaction: 52696 · SEC code covers open-market or private transactions · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. · This is the weighted average sales price representing 90,299 shares sold at prices ranging from $145.00 to $145.93 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. | 2026-11-19 | 2026-11-20 | ≈ $13,098,772.94 90,299 shares/units | SEC 4 | Follow |
| Schaeffer Orlov S Nicole Chief People Strategy Officer · INSMED Inc | INSM INSMED Inc | Exercise or conversionFiling detailsSEC transaction code M Common Stock · Direct ownership · Reported balance after transaction: 142995 · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. | 2026-11-19 | 2026-11-20 | 45,700 shares/units | SEC 4 | Follow |
| Schaeffer Orlov S Nicole Chief People Strategy Officer · INSMED Inc | INSM INSMED Inc | Exercise or conversionFiling detailsSEC transaction code M Common Stock · Direct ownership · Reported balance after transaction: 97295 · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. · Includes 141 shares acquired through the Company's 2018 Employee Stock Purchase Plan. | 2026-11-19 | 2026-11-20 | 55,400 shares/units | SEC 4 | Follow |
Form 4 buy and sell codes cover open-market or private transactions. Form 13F shows quarterly reported holdings. Position changes can have causes other than trading. Disclosures are delayed and provided for research.